CoChat

Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity

Open access
Stiles, Bangyan, Wang, Ying, Stahl, Andreas, Bassilian, Sara, Lee, W. Paul, Kim, Yoon-Jung, Sherwin, Robert, Devaskar, Sherin, Lesche, Ralf, Magnuson, Mark A., Wu, Hong · 2004 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

In the liver, insulin controls both lipid and glucose metabolism through its cell surface receptor and intracellular mediators such as phosphatidylinositol 3-kinase and serine-threonine kinase AKT. The insulin signaling pathway is further modulated by protein tyrosine phosphatase or lipid phosphatase. Here, we investigated the function of phosphatase and tension homologue deleted on chromosome 10 (PTEN), a negative regulator of the phosphatidylinositol 3-kinase/AKT pathway, by targeted deletion of Pten in murine liver. Deletion of Pten in the liver resulted in increased fatty acid synthesis, accompanied by hepatomegaly and fatty liver phenotype. Interestingly, Pten liver-specific deletion causes enhanced liver insulin action with improved systemic glucose tolerance. Thus, deletion of Pten in the liver may provide a valuable model that permits the study of the metabolic actions of insulin signaling in the liver, and PTEN may be a promising target for therapeutic intervention for type 2 diabetes.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0308617100

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Research works printed but not linked: 6

  1. Lee, W. N., Bassilian, S., Guo, Z., Schoeller, D., Edmond, J., Bergner, E. A. & Byerley, L. O. (1994) Am. J. Physiol. 266, E372-E383.8166257
  2. Asante-Appiah, E. & Kennedy, B. P. (2003) Am. J. Physiol. 284, E663-E670.
  3. Matsubara, M., Katayose, S. & Maruoka, S. (2003) Eur. J. Endocrinol. 148, 343-350.12611616
  4. Chanussot, F., Ulmer, M., Ratanasavanh, R., Max, J. P. & Debry, G. (1984) Int. J. Obes. 8, 259-270.6378817
  5. 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
  6. Carvalheira, J. B., Ribeiro, E. B., Folli, F., Velloso, L. A. & Saad, M. J. (2003) Biol. Chem. Hoppe-Seyler 384, 151-159.

Cited by

See all 437

Metadata

Authors
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., & Wu, H.
Affiliations
  • Palo Alto Medical Foundation (US)
  • Departments of Molecular and Medical Pharmacology and Howard Hughes Medical Institute and Department of Pediatrics Neonatology and Developmental Biology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; Research Institute, Palo Alto Medical Foundation and Stanford School of Medicine, Palo Alto, CA 94301; Department of Pediatrics, Harbor-UCLA Medical Center, Los Angeles, CA 90502; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT...
Venue
Proceedings of the National Academy of Sciences
Published
2004-02-09
Volume
101
Issue
7
Pages
2082-2087
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2003295985
Cited by
436
References
50
Citations by year
2026: 10 · 2025: 24 · 2024: 12 · 2023: 18 · 2022: 21 · 2021: 23 · 2020: 16 · 2019: 15 · 2018: 19 · 2017: 21 · 2016: 18 · 2015: 33 · 2014: 23 · 2013: 27 · 2012: 24
FWCI
6.51
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Howard Hughes Medical Institute
  • National Institutes of Health (DK56339)
  • National Cancer Institute (CA-98-013)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK-56339, P30DK056339)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
PTEN, liver-specific gene deletion, hepatic fatty acid synthesis, hepatic steatosis, insulin sensitivity, insulin signaling, PI3K/Akt signaling, glucose tolerance, hepatomegaly, type 2 diabetes, protein tyrosine phosphatase
MeSH terms
Adipose Tissue, Animals, Blood Glucose, Fasting, Fatty Acids, Fatty Liver, Gluconeogenesis, Glucose Tolerance Test, Glycogen, Hepatomegaly, Insulin, Insulin Resistance, Liver, Organ Specificity, RNA, Messenger, Gene Deletion, Hepatocytes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. https://app.cochat.ai/papers/10.1073/pnas.0308617100
The paper
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., & Wu, H. (2004). Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0308617100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.